These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28273042)

  • 1. BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of Infliximab.
    Jones J; Borgaonkar M; Siffledeen J; O'Reilly R; Anger D; Dajnowiec D; Williamson M; Dyrda P
    Manag Care; 2017 Feb; 26(2):41-48. PubMed ID: 28273042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
    Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey.
    Kanters S; Thorlund K; Perampaladas K; Dyrda P; Williamson M; Jones J
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):1015-21. PubMed ID: 26068138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perspectives on Intravenous Biologics for Rheumatologic Disease.
    Grisanti L; Kwiatkowski A; Dyrda P; Field E; Grisanti J; Hatem J; Dehoratius RJ; Gaylis N
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1234-1242. PubMed ID: 30221490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis.
    Yazici Y; McMorris BJ; Darkow T; Rosenblatt LC
    Clin Exp Rheumatol; 2009; 27(6):907-13. PubMed ID: 20149304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients.
    Mazzuoli S; Tricarico D; Demma F; Furneri G; Guglielmi FW
    PLoS One; 2016; 11(11):e0166443. PubMed ID: 27851772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study.
    Van Assche G; Vermeire S; Noman M; Amant C; Weyts E; Vleminckx A; Vermeyen MJ; Rutgeerts P
    J Crohns Colitis; 2010 Sep; 4(3):329-33. PubMed ID: 21122522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.
    Michielan A; Martinato M; Favarin A; Zanotto V; Caccaro R; Caruso A; Sturniolo GC; D'Incà R
    Dig Liver Dis; 2015 May; 47(5):372-7. PubMed ID: 25708258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.
    Principi M; Losurdo G; La Fortezza RF; Lopolito P; Lovero R; Grillo S; Bringiotti R; Ierardi E; Di Leo A
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):165-70. PubMed ID: 26114175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life evaluated by Short Form-8 in patients with rheumatoid arthritis who were receiving infusion of infliximab.
    Ogawa H; Itokazu M; Ito Y; Matsumoto K; Takigami I
    Mod Rheumatol; 2009; 19(1):27-32. PubMed ID: 18712459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.
    Ollendorf DA; Massarotti E; Birbara C; Burgess SM
    J Manag Care Pharm; 2005 Jun; 11(5):383-93. PubMed ID: 15934797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: a prospective multicenter cohort study.
    Babouri A; Roblin X; Filippi J; Hébuterne X; Bigard MA; Peyrin-Biroulet L
    J Crohns Colitis; 2014 Feb; 8(2):161-5. PubMed ID: 23994253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.
    Gossec L; Le Henanff A; Breban M; Vignon E; Claudepierre P; Devauchelle V; Wendling D; Lespessailles E; Euller-Ziegler L; Sibilia J; Perdriger A; Alexandre C; Dougados M
    Rheumatology (Oxford); 2006 Jul; 45(7):859-62. PubMed ID: 16436489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
    Kapetanovic MC; Larsson L; Truedsson L; Sturfelt G; Saxne T; Geborek P
    Arthritis Res Ther; 2006; 8(4):R131. PubMed ID: 16869978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of reducing duration of infliximab infusion.
    Fukuyo S; Saito K; Yamaoka K; Sawamukai N; Hirata S; Nawata M; Iwata S; Tanaka Y
    Mod Rheumatol; 2014 Mar; 24(2):275-80. PubMed ID: 24251990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
    Ollendorf DA; Lidsky L
    Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.